The information on DCAGuide.org is only as reliable as the people responsible for it. This page introduces the individuals who write, edit, and medically review content on this site, explains what their roles involve, and discloses any relevant affiliations or potential conflicts of interest.
Transparency about authorship is not a formality here. DCA is a topic where motivated reasoning — in both directions — is easy to find. Readers deserve to know who is making editorial judgments, on what basis, and with what professional background.
Medical Writer and Site Supervisor
Role: Medical writer, editorial lead
Location: Frankfurt, Germany
Training: Clinical healthcare studies, Kyiv Medical College No. 4, Kyiv, Ukraine
Conflict of interest: No financial relationship with any DCA manufacturer, supplier, distributor, or clinic offering DCA therapy
Daria Matej completed clinical healthcare studies in Kyiv before relocating to Germany, where her clinical background shifted increasingly toward medical writing and evidence communication. Her focus on DCA is not the result of a research posting or academic assignment — it came through direct personal experience with the compound as a caregiver, during a period when her mother was living with Stage III lung adenocarcinoma and had exhausted the options her oncologists could offer within standard protocols.
The stabilization that followed the introduction of sodium dichloroacetate was not what she had expected, and it prompted her to do what her training had prepared her to do: read the evidence systematically and critically. What she found was not a shortage of research — it was a shortage of trustworthy, accessible communication about research that already existed. That gap became the editorial mission of this site.
In practice, Daria’s work at DCAGuide.org involves identifying topics based on reader need and the state of the published literature, researching primary sources (clinical trials, peer-reviewed papers, case series, pre-clinical studies, and conference presentations), and writing content that is accurate, appropriately caveated, and readable by a motivated non-specialist. She does not accept payment or editorial direction from any commercial entity connected to DCA.
Areas of focus: Metabolic oncology, DCA pharmacology, mitochondrial medicine, endometriosis and chronic fatigue syndrome as metabolic conditions
Professional profile: LinkedIn
Medical Reviewer
Role: Medical reviewer
Location: Berlin, Germany
Specialties: Hematology, Oncology, Immunology, Internal Medicine, Palliative Medicine
Training: Ulm University — MD, PhD; board-certified in internal medicine, hematology and oncology, and palliative medicine
Conflict of interest: No financial relationship with any DCA manufacturer, supplier, or clinic
Dr. Norman Walter brings more than two decades of frontline oncology experience to his role as medical reviewer for DCAGuide.org. He currently heads the Department of Hematology, Oncology, and Immunology at Helios Klinikum Berlin-Buch, a position he has built toward over a career that began with thirteen years at Charité Universitätsmedizin Berlin — one of Europe’s most prominent university hospital systems — and progressed through successive senior and leadership roles at Helios.
His academic record spans more than twenty peer-reviewed publications and over ten presentations at national and international scientific congresses. His research concentrates on three intersecting areas — cellular immunotherapies, metabolic cancer therapies, and personalized medicine — all of which bear directly on the questions DCAGuide.org addresses. Outside the clinic, he chairs the scientific and medical council of the Lebenshaus Foundation, contributing to evidence standards for the care of patients with serious hematologic and oncologic diseases, and has held management consulting roles with McKinsey & Company and Dr. Becker Klinikgesellschaft.
His review role at DCAGuide.org is straightforward: he reads medically significant content before it is published, assesses it against current standards in oncology and internal medicine, and flags anything that overstates the evidence, misrepresents risk, or would mislead a clinician or patient trying to use the information responsibly. His involvement does not constitute endorsement of DCA as a treatment, and his name appearing on an article indicates only that its content has been reviewed for factual and clinical accuracy.
Professional profiles: LinkedIn · X / Twitter
How Authorship Works on This Site
Every page on DCAGuide.org that contains health information displays the name of the person who wrote or reviewed it, along with the date it was last reviewed. Author and reviewer names link to this page.
Where content has been updated, the “last reviewed” date reflects the most recent substantive review, not the original publication date. Corrections to factual errors are noted directly on the relevant page with the date the correction was made.
If you believe a specific page contains inaccurate or misleading information, please contact us at info@dcaguide.org. We review every correction request and respond to those that identify genuine errors.
Page last reviewed: April 2026